Background: Strong evidence suggests a correlation between pharmacodynamics (PD) index and antibiotic efficacy while dose adjustment should be considered in critically ill patients due to modified pharmacokinetic (PK) parameters and/or higher minimum inhibitory concentrations (MICs). This study aimed to assess pharmacodynamic (PD) target attainment considering both antibiotics serum concentrations and measured MICs in these patients. Method: A multicentric prospective open-label trial conducted in 11 French ICUs involved patients with Gram-negative bacilli (GNB) ventilator-associated pneumonia (VAP) confirmed by quantitative cultures. Results: We included 117 patients. Causative GNBs were P. aeruginosa (40%), Enterobacter spp. (23%), E. coli (20%), and Klebsiella spp. (16%). Hence, 117 (100%) patients received β-lactams, 65 (58%) aminoglycosides, and two (1.5%) fluoroquinolones. For β-lactams, 83% of the patients achieved a Cmin/MIC > 1 and 70% had a Cmin/MIC > 4. In the case of high creatinine clearance (CrCL > 100 mL/min/1.73 m2), 70.4% of the patients achieved a Cmin/MIC ratio > 1 versus 91% otherwise (p = 0.041), and 52% achieved a Cmin/MIC ratio > 4 versus 81% (p = 0.018). For aminoglycosides, 94% of the patients had a Cmax/MIC ratio > 8. Neither β-lactams nor aminoglycosides PK/PD parameters were associated clinical outcomes, but our data suggest a correlation between β-lactams Cmin/MIC and microbiological success. Conclusion: In our ICU patients treated for GNB VAP, using recommended antibiotic dosage led in most cases to PK/PD targets attainment for aminoglycosides and β-lactams. High creatinine clearance should encourage clinicians to focus on PK/PD issues.
Cardiac arrest is a major medical emergency with survival rates below 10%. Among care components after the return of spontaneous circulation (ROSC), sedation remains poorly standardized. Initial sedation may be withheld from the most severely ill patients in order to facilitate the early identification of neurological recovery. We analyzed data from the prospective AfterROSC1 and AfterROSC2 cohort studies. We compared post-cardiac arrest patients in whom sedation was vs. was not started during pre-hospital care. Patients' characteristics, day-90 survival, and day-90 survival with a favorable neurological outcome were analyzed (modified Rankin scale 0-3). The day-90 neurological outcome was adjusted for disease severity (modified Cardiac Arrest Hospital Prognosis score [mCAHP]) and for center effect. Of the 1596 included patients, 1324 (83%) were and 272 (17%) were not sedated before intensive-care-unit (ICU) admission. In both groups, males and cardiac arrest at home predominated. The mCAHP score was higher in the group without pre-ICU sedation (median: 90 [70-106] vs. 105 [90-116], P=0.001). The pre-ICU sedated group had a higher proportion of patients with a favorable day-90 outcome (32.4% vs. 11.8%; P=0.001). This difference remained significant after adjustment for the mCAHP score and center (adjusted odds ratio, 2.19; 95% confidence interval, 1.31-3.65; P=0.003) but not after propensity score adjustment: 1.40 [95%CI: 0.70 ; 2.09] (P = 0.26). The decision of sedation started after ROSC and before ICU admission was associated with a good functional recovery on day 90. However, the design of this study does not allow us to establish a causal link between pre-hospital sedation and improved neurological recovery. In particular, it is not possible to formally rule out residual indication bias. A randomized trial assessing the effect of early sedation on treatment strategies and patient outcomes is needed.